| Model Number |
RONYX30022UX |
| Medical Device Problem Code |
Device Dislodged or Dislocated (2923)
|
| Health Effect - Clinical Code |
No Consequences Or Impact To Patient (2199)
|
| Date of Event |
02/14/2020
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Product analysis summary: the stent was not present on the balloon and did not return for analysis.Crimp impressions were visible on the exposed balloon surface.The balloon folds were remained intact.The inner lumen patency was verified with a 0.015 inch.A kink was evident to the distal shaft.No other damage was evident to the remainder of the device.If information is provided in the future, a supplemental report will be issued.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information: the lcx artery was very torturous and calcified.The resolute onyx was inspected before use and prepped per ifu with no issues noted.No difficulties were noted during removal of the protective sheath/packaging stylette.The lesion was pre-dilated with cutting bal loons.The telescope device was inspected before use with no issues noted.No resistance was noted when advancing the telescope.Excessive force was not used.The resolute onyx did not pass through a previously deployed stent or cell of a stent.No resistance was noted between the resolute onyx and other devices used in the procedure.It was reported that the stent failed to cross the lesion, so the delivery system and stent were both removed.No resistance was noted during withdrawal of the resolute onyx.Excessive force was not used when removing the resolute onyx.It was reported that stent dislodgement occurred during withdrawal of the resolute onyx.The resolute onyx was pulled back into the telescope and the two devices were removed together.If information is provided in the future, a supplemental report will be issued.
|
| |
|
Additional Manufacturer Narrative
|
|
If information is provided in the future, a supplemental report will be issued.
|
| |
|
Event or Problem Description
|
|
During a procedure an attempt was made to use one resolute onyx rx coronary drug eluting stent, one telescope guide extension catheter, and one launcher to treat a tortuous and calcified lesion located in the left circumflex artery.The lesion was pre-dilated.It was reported that stent dislodgement occurred during insertion into the homeostatic valve.It was stated when the device came out of the coronaries the stent was still on the balloon.It was reported that the telescope was out of the guide wire.It was stated that when the stent came off the balloon at the distal end of the telescope.All devices were removed including the wire.The stent was not seen in the guide or telescope and was found in the touey.The stent was found when a new guide wire was advanced and resistance was felt.It was stated that the telescope could barely enter the left main and the telescope tip may have gotten distorted.The procedure was completed using a new guide, new wire, new telescope and a new resolute onyx stent.The patient was reported to be alive with no injuries.
|
| |
|
Additional Manufacturer Narrative
|
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
| |
|
Search Alerts/Recalls
|